Medicines and Healthcare products Regulatory Agency
CERTIFICATE of GDP COMPLIANCE OF A DISTRIBUTOR OF ACTIVE SUBSTANCES FOR USE AS STARTING MATERIALS IN MEDICINAL PRODUCTS FOR HUMAN USE
Has been inspected under the national inspection programme in accordance with The Human Medicines Regulations 2012 (SI 2012/1916)
From the knowledge gained during inspection of this active substance distributor, the latest of which was conducted on 28/08/2020, it is considered that it complies with the principles of good distribution practice for active substances referred to in Regulation B17 and C17 of The Human Medicines Regulations 2012 (SI 2012/1916).
This certificate reflects the status of the premises at the time of the inspection noted above and should not be relied upon to reflect the compliance status if more than five years have elapsed since the date of that inspection. However this period of validity may be reduced using regulatory risk management principles, by an entry in the Restrictions or Clarifying Remarks field.
This certificate is valid only when presented with all pages.
The authenticity of this certificate may be verified in MHRA-GMDP. If it does not appear please contact the issuing authority.
Any restrictions or clarifying remarks related to the scope of this certificate(For All Users):
In accordance with the MHRA risk based inspection procedures the GDP certificate has been re-issued for this site that is authorised for administrative functions only. This certificate is issued based on a remote assessment of GDP compliance during COVID-19 travel restrictions. A risk-based site inspection programme remains in force.
| 28/08/2020 | Name and signature of the authorised person of the Competent Authority of United Kingdom |
| Confidential | |
| Medicines and Healthcare products Regulatory Agency | |
| Confidential |